← Back to Search
Global Use Of Asbestos And The Incidence Of Mesothelioma
Published 2004 · Medicine
Download PDFAnalyze on Scholarcy
Abstract In Western Europe, Scandinavia, North America, and Australia the manufacture and use of asbestos products peaked in the 1970s. Current incidences of mesothelioma range from 14 to 35 cases/million/year in 11 industrialized countries that had used asbestos 2.0 to 5.5 kg/capita/year about 25 years earlier. A significant linear correlation (r = 0.80, p 0.01) exists between the two variables. Accordingly, about 170 tons of produced and consumed asbestos will cause at least one death from mesothelioma, most often as a consequence of occupational exposure.
This paper references
Trends and geographical patterns of pleural mesotheliomas in the Netherlands 1970-87.
J. Meijers (1990)
Estimation of the past and future burden of mortality from mesothelioma in France.
A. G. Ilg (1998)
WHO Cancer Mortalit (2001)
asbestosis and cancer: the Helsinki criteria for diagnosis and attribution. Consensus report
A Tossavainen (1997)
Asbestos and cancer in Finland.
M. Huuskonen (1980)
Analysis of current trends in United States mesothelioma incidence.
B. Price (1997)
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos.
B. Järvholm (1999)
Recent data on cancer due to asbestos in Germany.
J. Rösler (1995)
Proceedings of the Asbestos Symposium for the Countries of Central and Eastern Europe
S Lehtinen (1998)
Trends in Mesothelioma Incidence in Norway
G. Mowé (1991)
Asbestos and cancer in Finland. Med Lav
MS Huuskonen (1995)
Recent data on cancer due to asbestos in Sweden.
A. Englund (1995)
Asbestos Institute. Chrysotile production and consumption
Health and Safety Commission. Health and Safety Statistics 2000/01. Her Majesty'$ Stationery Office
Past occupational exposure to asbestos among men in France.
M. Goldberg (2000)
Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995.
A. Karjalainen (1997)
Estimating the future developments in mesothelioma mortality due to historical asbestos use and its consequences for public health
A Burdorf (1998)
Prospects of occurrence of pleural mesothelioma in Italy
E Gaffuri (1991)
South African asbestos: production, exports, and destinations, 1959-1993.
J. Harington (1998)
ASBESTOS PRODUCTION : SURVIVORS COUNTING ASIAN COST
T. Kendall (1998)
Geography of mesothelioma: expected findings and paradoxes
L Giarelli (2000)
Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution.
A. Tossavainen (1997)
Asbest an der ArbeitspHitzen in der DDR. In: BIA-Report 3/95,HVBG
W Muglich (1995)
Asbestos. In: Anonymous. Chinese industrial minerals
W. Lu (1998)
Finnish Cancer Registry. Cancer incidence in Finland in 1999. Finnish Cancer Registry
Proceedings of the Asbestos Symposium for the Countries of Central and Eastern Europe. People and Work Research Reports 19. Finnish Institute of Occupational Health
S Lehtinen (1998)
Commission Directive 1999/77/EC (1999) on the marketing and use of certain dangerous substances and preparations (asbestos)
US Geological survey: mineral commodity summaries, January 2003.
R. Virta (2003)
Continuing increase in mesothelioma in Britain
J Peto (1995)
Future trends in mortality of French men from mesothelioma
A. Banaei (2000)
Malignant mesothelioma in Australia
A. Musk (2006)
Ecological Relationship between Mesothelioma Incidence/Mortality and Asbestos Consumption in Ten Western Countries and Japan
K. Takahashi (1999)
Asbest an der ArbeitspHitzen in der DDR
The European mesothelioma epidemic
J. Peto (1999)
International expert meeting on new advances in the radiology and screening of asbestos-related diseases.
A. Tossavainen (2000)
The incidence of mesothelioma in Australia
Australian Mesothelioma (1995)
US Geological survey: mineral commodity summaries
Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started.
T. Kjellstrom (2000)
World Trade Organization. Measures affecting asbestos and asbestos-containing products
Mesothelioma: cases associated with non-occupational and low dose exposures.
G. Hillerdal (1999)
Effets sur la santé des principaux types d'exposition à l'amiante
D. Douguet (1997)
A history of awareness of asbestos disease and the control of occupational asbestos exposures in The Netherlands.
L. Burdorf (1991)
This paper is referenced by
Targeted Therapy—Possible New Therapeutic Option for Malignant Mesothelioma?
K. Dobra (2008)
Environmental health survey in asbestos cement sheets manufacturing industry
F. A. Ansari (2007)
Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40
K. Leithner (2006)
Prognosis, Prediction and Risk Assessment in the Prevention and Treatment of Non-Small Cell Lung Cancer
M. Sandelin (2015)
Regulating nanoparticles : a complex balancing act
Sylvia Isabelle Sarah Dean (2016)
Geographic study of mortality due to mesothelioma in Peru and its evolution.
J. S. Torres-Roman (2020)
Asbestos related diseases among workers of asbestos processing plants in relation to type of production and asbestos use.
N. Szeszenia-Dąbrowska (2015)
Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis
Ro-Ting Lin (2007)
Current Asbestos Exposure and Future Need for Palliative Care in India
A. Jadhav (2019)
Reactive oxygen species-regulating proteins peroxiredoxin 2 and thioredoxin, and glyceraldehyde-3-phosphate dehydrogenase are differentially abundant in induced sputum from smokers with lung cancer or asbestos exposure
Annina M Rostila (2019)
LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma
M. Kim (2020)
Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005.
M. Huuskonen (2006)
Pleural mesothelioma mortality and asbestos exposure mapping in Italy.
L. Fazzo (2012)
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
O. D. Røe (2015)
STUDIES ON SYNDECAN-1 IN MESENCHYMAL TUMORS
Fang Zong (2010)
Treatments of asbestos containing wastes.
D. Spasiano (2017)
Environmental asbestos exposure sources in Korea
Dong-Mug Kang (2016)
Molecular and genetic changes in asbestos-related lung cancer.
P. Nymark (2008)
Asbestos: use, bans and disease burden in Europe
T. Kameda (2014)
Gene-Environment Interactions in the Development of Complex Disease Phenotypes
R. Ramos (2008)
Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
P. Jänne (2008)
Retrospective assessment of occupational asbestos exposure among 220 patients with respiratory cancer hospitalized at Vilnius University Institute of Oncology
R. Everatt (2005)
Mésothéliome pleural malin
A. Scherpereel (2007)
Epidemiology of mesothelioma and historical background.
J. Craighead (2011)
The emerging epidemic of environmental cancers in developing countries.
P. Vineis (2009)
Environmental and occupational risk factors for lung cancer.
I. Brüske-Hohlfeld (2009)
Malignant pleural mesothelioma: occupational and non-occupational asbestos exposures
A. Cheepsattayakorn (2016)
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
Asbestos is still with us: repeat call for a universal ban.
C. Ramazzini (2010)
Malignant mesothelioma as a difficult interdisciplinary problem
W. Rokicki (2017)
Title Transnational Dynamics Amid Poor Regulations : Taiwan ’ sAsbestos Ban Actions and Experiences
H. Wu (2017)
Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program
S. Metintaş (2017)See more